This topic contains a solution. Click here to go to the answer

Author Question: The patient is quadriplegic and receives oxybutynin (Ditropan), an anticholinergic drug, to increase ... (Read 20 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
The patient is quadriplegic and receives oxybutynin (Ditropan), an anticholinergic drug, to increase his bladder capacity. What is an important assessment of this patient by the nurse?
 
  1. Is he irritable?
  2. Is he constipated?
  3. Is he gaining weight?
  4. Is he lethargic?

Question 2

The physician has ordered bethanechol (Urecholine), a cholinergic drug, for the patient with urinary retention. The patient also has an enlarged prostate gland. What is the priority action by the nurse?
 
  1. Hold the drug and prepare to catheterize the patient.
  2. Administer the drug and measure urinary output.
  3. Administer the drug and push fluids.
  4. Hold the drug and contact the physician.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shewald78

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Correct Answer: 2
Rationale: Anticholinergics slow gastrointestinal (GI) motility and can increase the risk for constipation. Anticholinergic drugs do not cause lethargy. Anticholinergic drugs do not cause weight gain. Anticholinergic drugs do not cause irritability.

Answer to Question 2

Correct Answer: 4
Rationale: Bethanechol (Urecholine) relaxes the urinary sphincter and increases voiding pressure. It is contraindicated with any physical obstruction of the urinary tract, such as an enlarged prostate gland. Measuring urinary output is inappropriate; the patient should not receive the drug. There should be no need for catheterization as long as the drug is not given. The drug should not be given; pushing fluids would exacerbate the problem.




daltonest1984

  • Member
  • Posts: 536
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


amynguyen1221

  • Member
  • Posts: 355
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

For a complete list of videos, visit our video library